U.S. Patent Office Revises Guidelines After Drugmakers Complain

Dec 17, 2014, 00:00 by Michael Croft

WSJ | The U.S. Patent and Trademark Office has issued revised guidelines for its examiners that should make it easier for drug makers and biotechs to obtain patents for their inventions.

December 17, 2014 | The U.S. Patent and Trademark Office has issued revised guidelines for its examiners that should make it easier for drug makers and biotechs to obtain patents for their inventions. WSJ